Comparable effect of recombinant and plasma-derived human fibrinogen concentrate on ex vivo clot formation after cardiac surgery

J Thromb Haemost. 2012 Aug;10(8):1696-8. doi: 10.1111/j.1538-7836.2012.04823.x.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood Coagulation Tests
  • Blood Loss, Surgical / prevention & control*
  • Blood Transfusion
  • Coronary Artery Bypass / adverse effects*
  • Female
  • Fibrinogen / therapeutic use*
  • Hemostatic Techniques*
  • Hemostatics / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Postoperative Hemorrhage / blood
  • Postoperative Hemorrhage / etiology
  • Postoperative Hemorrhage / prevention & control*
  • Recombinant Proteins / therapeutic use
  • Sweden
  • Time Factors
  • Treatment Outcome

Substances

  • Hemostatics
  • Recombinant Proteins
  • Fibrinogen